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Abstract
Dynamic thalamic regulation of sensory signals allows the cortex to adjust better to rapidly changing behavioral,
physiological and environmental demands. To fulfill this role, thalamic neurons must themselves be subjected to constantly
changing modulatory inputs that originate in multiple neurochemical pathways involved in autonomic, affective and
cognitive functions. Our overall goal is to define an anatomical framework for conceptualizing how a ‘decision’ is made on
whether a trigeminovascular thalamic neuron fires, for how long, and at what frequency. To begin answering this question,
we determine which neuropeptides/neurotransmitters are in a position to modulate thalamic trigeminovascular neurons.
Using a combination of in-vivo single-unit recording, juxtacellular labeling with tetramethylrhodamine dextran (TMR) and
in-vitro immunohistochemistry, we found that thalamic trigeminovascular neurons were surrounded by high density of
axons containing biomarkers of glutamate, GABA, dopamine and serotonin; moderate density of axons containing
noradrenaline and histamine; low density of axons containing orexin and melanin concentrating hormone (MCH); but not
axons containing CGRP, serotonin 1D receptor, oxytocin or vasopressin. In the context of migraine, the findings suggest that
the transmission of headache-related nociceptive signals from the thalamus to the cortex may be modulated by opposing
forces (i.e., facilitatory, inhibitory) that are governed by continuous adjustments needed to keep physiological, behavioral,
cognitive and emotional homeostasis.
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Introduction
Historically, the thalamus was viewed as a simple relay station
for sensory information from the periphery to the cortex. This
view has been replaced by the concept that instead of ‘just’
transferring sensory signals from subcortical nuclei to the cortex,
thalamic neurons play central role in the selection, amplification,
and prioritization process that determines which type of informa-
tion should be made available to the cortex at any given time [1,2].
Being the so-called ‘gate-keeper’ of the cortex, thalamic neurons
regulate the flow of rapidly-changing sensory signals, thus allowing
the cortex to adjust to the constantly evolving behavioral and
environmental demands [1].
To regulate the amount of sensory signals that reach the cortex,
thalamic neurons must themselves be subjected to a variety of
modulatory inputs that originate in cortical, hypothalamic,
brainstem, spinal and intrathalamic nuclei [1,3–6]. In the context
of somatosensory and nociceptive information, the more exten-
sively studied networks that drive and/or modulate the activity of
relay thalamic neurons are the excitatory glutamatergic input
originating in corticothalamic, spinothalamic and medial lemnis-
cus tract neurons, and the inhibitory GABAergic input involving
the reticular thalamic nucleus [7,8]. The excitatory glutamate
input, acting through metabotropic mGluRs, is capable of
producing sustained neuronal firing whereas the inhibitory GABA
input, acting through the GABAb receptor is capable of switching
off the sustained neuronal activity [8].
Far less is known about the regulation of relay thalamic neurons
by other neurotransmitters and neuropeptides [3] from various
brain regions. Candidates include those from the brainstem and
hypothalamus. Brainstem inputs include serotonergic projections
from raphe nuclei [9,10], noradrenergic projections from locus
coeruleus and the A5 catecholamine group in the pons [9–11], and
dopaminergic projections from periaqueductal gray, and the
lateral parabrachial nucleus [12–16]. Hypothalamic inputs include
additional dopaminergic projections from A11/A13 [12–16],
histaminergic projections from the tuberomammillary nucleus
[17,18], orexinergic projections from the perifornical, dorsomedial
and lateral hypothalamus [19,20], and melanin-concentrating
hormone (MCH) projections from the lateral hypothalamus [21–
23].
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on relay thalamic nuclei suggests that the modulation of individual
neurons is rather complex, likely subjected to opposing forces
driven by a variety of changing external and internal conditions
that require constant behavioral, physiological, and affective
adjustments. Our overall goal is to understand how ‘a decision’
is made on whether or not a relay thalamic neuron fires, for how
long, and at what frequency. To start answering this question, we
must first determine which neuropeptides/neurotransmitters are
in a position to govern the activity of individual thalamic neurons
that share a common function; a task never taken before. In the
current study we describe an array of neuropeptides/neurotrans-
mitters that may modulate individual, physiologically-identified
thalamic trigeminovascular neurons believed to play a role in the
generation of headache perception during migraine. The under-
standing of this neurobiology will allow for a basis to determine
functional neurotransmission between the thalamus and cortex
related to multiple clinical components of migraine including pain
(somatosensory cortex), cognition (frontal cortex), memory (hip-
pocampus), altered perception (parietal cortex), interoception and
awareness (insular cortex).
Materials and Methods
Animal preparation
Experiments were approved by the Institutional Animal Care
and Use Committee at Harvard Medical School and Beth Israel
Deaconess Medical Center, and conducted in accordance of NIH
guide for the care and use of laboratory animals. Thirty-two male
Sprague-Dawley rats weighing 250–350 g were initially anesthe-
tized with a single dose of Brevital sodium (45 mg/kg i.p.) to allow
endotracheal intubation and cannulation of the right femoral vein.
Each rat was then mounted on a stereotaxic frame and connected
to an inhalation anesthesia system (O
2/Isoflurane 2.5% for
craniotomies; 1–1.2% for maintenance during the rest of the
experiment, delivered at 100 ml/min). End-tidal CO2, respiratory
and heart rate, blood oxygen saturation and body temperature
were continuously monitored and kept within a physiological
range. One craniotomy was performed at the left lambdoid suture
to expose and stimulate the meninges overlying the left transverse
sinus. A second craniotomy was performed at the right parietal
bone to allow the introduction of a glass micropipette into the
posterior thalamus for recording and juxtacellular iontophoresis of
an anterograde tracer, as described previously [24]. The exposed
dura was kept moist throughout the experiment, using synthetic
interstitial fluid (SIF; pH 7.2). After surgery, a lactated ringer’s
solution with a mixture of paralytic agents (vecuronium/doxacur-
ium) was continuously infused via the femoral vein cannula
(0.25 mg/kg/hr).
Single-unit juxtacellular recording and iontophoresis
A glass micropipette (20–30 MV impedance) filled with a 3%
solution of the tracer tetramethylrhodamine dextran (TMR; 3,000
MW, anionic, lysine fixable; D-3308, Invitrogen) in 0.9% NaCl,
was lowered into the right posterior thalamus while searching for
single-unit responses to electrical stimulation of the contralateral
dura (0.8 ms, 0.5–3.0 mA, 1 Hz). Thalamic neurons responding to
the electrical stimulation were additionally tested for responses
induced by mechanical (calibrated von-Frey monofilament) and
chemical (1 M KCl) stimulation of the dura (Fig. 1A). Response
was defined as an increase in firing rate that was at least 50%
higher than baseline. Spikes from neurons responding to all three
types of stimuli were amplified, filtered and acquired in a window
discriminator to be further analyzed using Spike2 software (CED,
Cambridge, UK). Once the electrophysiological characterization
of neuronal responses was finalized, the cell was iontophoretically
injected using the recording glass micropipette by delivering pulses
of positive current (1–10 nA) at 250-ms on/off intervals by means
of a computer-controlled microelectrode amplifier (Axoclamp
900A, Molecular Devices), as described elsewhere [25] (Fig. 1B).
In some experiments, more than one injection was performed in
different locations of the posterior thalamus. After a period of 10–
20 min of juxtacellular filling, the micropipette was slowly pulled
out of the brain; the animal remained anesthetized for 30 minutes
and then was prepared for perfusion.
Histological processing
Rats were injected with an overdose of pentobarbital sodium
(100 mg/kg) and perfused intracardially with 200 ml heparinized
saline, followed by a fixative solution consisting in 400 ml of 0.1 M
phosphate buffered saline (PBS), 4% paraformaldehyde and
0.05% picric acid. Only when required for the staining protocol,
rats were perfused with 200 ml of PBS followed by a fixative
solution containing 75 ml of 4% ethylcarbodiimide in 0.1 M PBS.
Brains were removed, soaked in the fixative solution for 2 hrs, and
cryoprotected in 30% sucrose phosphate buffer for 48 hrs. Brains
were then frozen and cut into serial coronal sections (60–80 mm-
Figure 1. Identification and labeling of individual thalamic
trigeminovascular neurons. (A) Neuronal responses to electrical
(1 mA, 0.8 ms), mechanical (von Frey filament: 4, 63 g) and chemical
(1 M KCl solution) stimulation of the dura overlying the left transverse
sinus. (B) Synchronization of neuronal activity during iontophoretic
injection of TMR by delivering pulses of current (1–10 nA) at 250 ms on/
off intervals through the recording glass micropipette.
doi:10.1371/journal.pone.0103929.g001
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and mounted on slides for a rapid visualization and localization of
each cell body and its dendrites using epifluorescence microscopy.
Immunofluorescence
Brain sections containing successfully injected neurons were
pre-incubated at room temperature in PBS containing 2% fetal
bovine serum albumin (FSA) and 1% Triton X-100 for 1 hr.
Sections were then incubated at 4uC for 48 hrs in the same
blocking solution with one of the following primary antibodies: (i)
mouse anti-Serotonin Transporter, SERT (1:5,000 dilution;
Millipore); (ii) mouse anti-Tyrosine Hydroxylase, TH (1:5,000;
Immunostar); (iii) rabbit anti-Dopamine b-Hydroxylase, DBH
(1:5,000; Immunostar); (iv) goat anti-Orexin A (1:2,500; Santa
Cruz); (v) rabbit anti-Calcitonin Gene Related Peptide, CGRP
(1:5,000; Chemicon); (vi) rabbit anti-5HT1D receptor (1:50,000;
Courtesy of Andrew Ahn, University of Florida); (vii) rabbit anti-
Oxytocin (1:10,000; Immunostar); (viii) goat anti-Vasopressin
(1:1,000; Immunostar); (ix) rabbit anti-Histamine (1:3,000; Im-
munostar; ethylcarbodiimide perfusion); (x) guinea pig anti-
Vesicular Glutamate Transporter 2, VGluT2 (1:2,500; Millipore);
(xi) rabbit anti-Vesicular GABA Transporter, VGaT (1:1,000;
Phosphosolutions); (xii) Melanin Concentrating Hormone, MCH
(1:1,000; Courtesy of Terry Maratos-Flier, Harvard Medical
School). The sections were washed multiple times and then
incubated in PBS containing 2% FSA and 0.5% Triton X-100 for
2 hrs at room temperature with the corresponding fluorescent
secondary antibody (Alexa Fluor 488; Invitrogen) against the Ig’s
of the animal in which the primary antibody was raised (dilution
range 1:200–1:1,000). Immunostained sections were serially
mounted on glass slides and coverslipped with fluorescent
mounting media with or without DAPI counterstaining.
Digital imaging of thalamic labeling
Digital imaging of each of the neuronal cell bodies and
dendrites injected with TMR, as well as the axonal network of
the different neurotransmitters/neuropeptides was performed
using epifluorescence scanning microscopy that compiled 1–
1.5 mm-thick scans using z-stacking software (Leica). Using
individual z-stack images, orthogonal views of the y–z and x–z
planes were also created to provide additional evidence for close
apposition, and thus probable contact. Immunofluorescent label-
ing of TMR was detected by excitation/emission at 551/624 nm
(red). For the axonal labeling of neurotransmitters/neuropeptides
with Alexa Fluor 488, the immunolabeling was detected by
excitation/emission at 455/520 nm (green). DAPI counterstaining
was detected by excitation/emission at 358/461 nm (blue). Co-
labeling of the different structures was achieved by superimposi-
tion of the red, green and blue images. The anatomical analysis
and localization of cell bodies was based on a rat brain atlas [26].
Quantitative measures were performed to obtain the relative
innervation density of neurotransmitters/neuropeptides in the
thalamic regions of interest. A qualitative approach was used to
determine close apposition between immunopositive axons and
thalamic trigeminovascular neurons.
Results
Identification and juxtacellular labeling of thalamic
trigeminovascular neurons
Forty-seven thalamic neurons that responded to electrical,
mechanical and chemical stimulation of the contralateral dura
were classified as trigeminovascular neurons [24]. Twenty-four of
these neurons were successfully injected with TMR, yielding a
detailed, high-resolution labeling of the cell body (seen in 1 or
2 sections), dendritic tree and proximal segment of the parent
axon (extending over 5–6 sections) within the thalamus. In each of
these cases, attempts were made to co-label the brain sections
containing the TMR-positive trigeminovascular neurons with a
different neuropeptide/neurotransmitter. Eighteen cases yielded
successful labeling of both trigeminovascular neurons (TMR) and
axons stained for markers of glutamate (n=2), GABA (n=2),
serotonin (n=3), noradrenalin (n=2), dopamine (n=3), histamine
(n=2), orexin (n=2), MCH (n=2), CGRP (n=2), 5HT1D
receptor (n=2), oxytocin (n=1) and vasopressin (n=1).
Innervation of thalamic trigeminovascular neurons by
the spinal trigeminal (SpV) and the reticular thalamic
nucleus (Rt)
Glutamatergic innervations. Glutamatergic innervation
was determined using Vesicular Glutamate Transporter 2
(Fig. 2). Axons immunoreactive to VGluT2, thus containing the
excitatory neurotransmitter glutamate, were present at high
density in all thalamic nuclei known to contain trigeminovascular
neurons including ventral posteromedial (VPM), posterior (Po),
lateral posterior (LP) and laterodorsal (LD). When examined in
sections containing the trigeminovascular neuron(s), dense
VGluT2 immunopositive vesicles were seen in close apposition
to the cell body, proximal and distal dendrites (Fig. S1).
GABAergic innervations. GABAergic innervation was de-
termined using Vesicular GABA Transporter (Fig. 3). Axons
immunoreactive to VGaT, thus containing the inhibitory neuro-
transmitter GABA, were present at high density in all thalamic
nuclei known to contain trigeminovascular neurons. When
examined in sections containing the trigeminovascular neuron(s),
dense VGaT immunopositive vesicles were seen in close apposi-
tion to the cell body, proximal and distal dendrites (Fig. S2).
Brainstem innervation of thalamic trigeminovascular
neurons
Serotoninergic innervations. Serotoninergic innervation
was determined using Serotonin Transporter (Fig. 4), a stable
marker of serotoninergic fibers in the brain [27]. Axons
immunoreactive to SERT, thus containing the monoamine
neurotransmitter serotonin, were present at high density in all
thalamic nuclei known to contain trigeminovascular neurons.
When examined in sections containing the trigeminovascular
neuron(s), dense SERT immunopositive axons and varicosities
were seen in close apposition to the cell body, proximal and distal
dendrites (Fig. 5).
Noradrenergic innervations. Noradrenergic innervation
was determined using the enzyme Dopamine b-Hydroxylase
(Fig. 6). Axons immunoreactive to DBH, thus containing the
catecholamine neurotransmitter noradrenaline, were present at
moderate-to-high density in all thalamic nuclei known to contain
trigeminovascular neurons. When examined in sections containing
the trigeminovascular neuron(s), moderate density of DBH
immunopositive axons and varicosities were seen in close
apposition to the cell body, proximal and distal dendrites (Fig.
S3). These DBH axons originate in the locus coeruleus, the main
producer of noradrenalin in the brain.
Hypothalamic innervation of thalamic trigeminovascular
neurons
Dopaminergic innervations. Dopaminergic innervation
was determined using the enzyme Tyrosine Hydroxylase (Fig. 7).
Axons immunoreactive to TH, thus containing the catecholamine
Modulation of Thalamic Trigeminovascular Neurons
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thalamic nuclei known to contain trigeminovascular neurons.
When examined in sections containing the trigeminovascular
neuron(s), high density of TH immunopositive axons and
varicosities were seen in close apposition to proximal and distal
dendrites (Fig. S4). Because TH is present in noradrenergic and
dopaminergic cells, the interpretation of its labeling must take into
consideration these two neurotransmitters. We interpreted some of
the TH-positive axons as dopaminergic based on a recent
retrograde tracing study where we showed that the dopaminergic
cells group A11/A13 project to the same Po and LP areas in which
trigeminovascular neurons were labeled in the current study [28].
Histaminergic innervations. (Fig. 8). Axons immunoreac-
tive to histamine neurotransmitter were present at moderate
density in LP and LD, and lower density in VPM and Po. When
examined in sections containing the trigeminovascular neuron(s),
moderate density of histaminergic immunopositive axons and
varicosities were seen in close apposition to the cell body, proximal
and distal dendrites (Fig. S5). This histaminergic innervation
Figure 2. Glutamatergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive VGluT2 synaptic vesicles (green)
surrounding a thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Arrowheads indicate close apposition of VGluT2 positive axons and
the cell body and dendrites of the labeled neuron. Upper right: Location of the dura-sensitive neuron (red star) shown at left. Number in red indicates
distance from bregma (mm). Lower right: Fluorescent images showing VGluT2 axonal labeling in thalamic Po and VPM nuclei. Scale bars=100 mm.
Abbreviations: DLG, dorsal lateral geniculate; LPMR, lateral posterior thalamic, mediorostral; LPLR, lateral posterior thalamic, laterorostral part; VPL,
ventral posterolateral thalamic.
doi:10.1371/journal.pone.0103929.g002
Figure 3. GABAergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive VGaT synaptic vesicles (green) surrounding a
thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads indicate close
apposition of VGaT positive axons and the cell body and dendrites of the labeled neuron. Upper right: Location of the dura-sensitive neuron (red star)
shown at left. Number in red indicates distance from bregma (mm). Lower right: Fluorescent images showing VGaT axonal labeling in thalamic Po and
VPM nuclei. Scale bars=100 mm. Abbreviations: eml, external medullary lamina; ic, internal capsule; ZI, zona incerta.
doi:10.1371/journal.pone.0103929.g003
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the hypothalamus, the sole producers of histamine in the brain.
MCH innervations. (Fig. 9) Axons immunoreactive to
MCH were present at low density in all thalamic nuclei known
to contain trigeminovascular neurons. When examined in sections
containing the trigeminovascular neuron(s), low density of MCH
immunopositive axons and varicosities were seen in close
apposition only to distal dendrites (Fig. S6). These MCH axons
originate mainly in the lateral hypothalamus.
Orexinergic innervations. Orexinergic innervation was
determined by targeting the neuropeptide orexin A (Fig. 10).
Axons immunoreactive to orexin A were present at low density in
LP, LD, Po and VPM. When examined in sections containing the
trigeminovascular neuron(s), low density of orexinergic immuno-
positive axons and varicosities were seen in close apposition to the
proximal and distal dendrites, but not the cell body (Fig. S7).
These orexinergic axons originate mainly in the perifornical
hypothalamic area.
Thalamic trigeminovascular neurons are not innervated
by CGRP, 5HT1D, oxytocin or vasopressin
Surprisingly, we found no evidence for presence of CGRP-
positive axons in any thalamic nucleus containing trigeminovas-
cular neurons (positive identification of CGRP fibers in the
parvicellular division of the ventral posterior thalamic nucleus
confirms the validity of the negative staining in the thalamic nuclei
analyzed in this study) (Fig. 11A). Similarly, we found no evidence
for presence of 5HT1D receptors in the relevant thalamic nuclei.
Positive identification of 5HT1D afferents in the medullary dorsal
horn confirms the validity of the negative staining in the thalamic
nuclei analyzed in this study (Fig. 11B). Predictably, we also found
no evidence for innervation of thalamic trigeminovascular neurons
by oxytocin or vasopressin from neurons in the paraventricular or
supraoptic hypothalamic nuclei (Figs. 11C–D), demonstrating the
selectivity of the positive findings.
Density of thalamic innervation by the different
biomarkers
We processed all images containing immunohistochemical
evidence for thalamic innervation of the neurotransmitter/
neuropeptides, and calculated their relative density by using
binary maps (ImageJ). The binary map identifies all pixels
containing positive immunostaining and converts them to white
pixels; the remaining black pixels are considered lack of staining.
This data provide quantitative measures of density of innervation
of thalamic areas where juxtacellularly labeled trigeminovascular
neurons were found (Table 1 and Figs. S8 and S9).
Discussion
This proof-of-concept study defines a new molecular framework
for a more sophisticated thinking of the complexity of factors that
modulate the response properties of relay trigeminovascular
thalamic neurons. Most significant was the finding that such
neurons receive direct input from axons containing glutamate,
GABA, dopamine, noradrenaline, serotonin, histamine, orexin
and MCH but not from axons that contain oxytocin, vasopressin,
CGRP or the 5HT1D receptor (Fig. 12A). This diverse input
suggests that the transmission of headache-related nociceptive
signals from the thalamus to the cortex is modulated by potentially
opposing forces and that the so-called ‘decision’ of which system
(neuropeptide/neurotransmitter) will dominate the firing of a
trigeminovascular thalamic neuron at any given time is deter-
mined by the constantly changing physiological (sleep, wakeful-
ness, food intake, body temperature, heart rate, blood pressure),
behavioral (addiction, isolation), cognitive (attention, learning,
memory use) and affective (stress, anxiety, depression, anger)
adjustment needed to keep homeostasis (Fig. 12B).
The discharge mode of relay thalamocortical neurons is either
burst or tonic [1,29]. The burst discharge is commonly associated
with lower excitability, drowsiness, and in the context of headache,
responses to acute pain, whereas the tonic discharge has been
associated with higher excitability, wakefulness, and chronic pain
Figure 4. Serotoninergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive Serotonin Transporter axons (green)
surrounding a thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads
indicate close apposition of SERT positive axons and the cell body and dendrites of the labeled neuron. Upper right: Location of the dura-sensitive
neuron (red star) shown at left. Number in red indicates distance from bregma (mm). Scale bars=100 mm. Since SERT does not stain cell somas, it was
not possible to use this marker to identify the serotoninergic neurons in the raphe nuclei that project to the thalamic nuclei containing
trigeminovascular neurons. Abbreviations: Hb, habenula; MD, mediodorsal thalamic; CL, centrolateral thalamic.
doi:10.1371/journal.pone.0103929.g004
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neuropeptides found in this study to have close apposition with
thalamic trigeminovascular neurons can potentially shift their
firing mode from burst to tonic if it is excitatory, and from tonic to
burst if it is inhibitory. As in other systems, the action of each
neuropeptide/neurotransmitter on individual thalamic neuron
depends on the type of release and reuptake, the type of receptor
activated, and most likley the location of the neuron and its
projection targets in the cortex. Since this information is not
available for thalamic trigeminovascular neurons, which are the
subject of this study, speculation on possible roles of the identified
neuropeptides/neurotransmitters in setting thalamic transmission,
as it may be related to migraine headache, is based on their known
action in other systems.
Glutamate
Vesicular glutamate transporters (VGluTs) are responsible for
glutamate trafficking and for the subsequent regulated release of
this excitatory neurotransmitter at the synapse. Glutamate excites
relay thalamocortical neurons through NMDA receptors, if the
sensory stimulus is prolong and through non-NMDA receptors if
the sensory stimulus is brief [33,34]. Of the three isoforms of
VGluT, we opted to study VGluT2 because it is expressed most
densely in relay thalamic nuclei [35–39] and in ascending
trigeminal sensory neurons that project to VPM and Po [40,41].
Since VGluT1 axons originate in corticothalamic neurons, we
interpreted the presence of VGluT2 on thalamic trigeminovas-
cular neurons as constituting the main drive for activation of these
neurons by glutamatergic input they receive from ascending
trigeminothalamic (possibly dura-sensitive) neurons in SpV.
Dopamine
In the context of migraine, dopamine has been considered for its
role in promoting hypothalamic-mediated symptoms/prodromes
such as yawning and nausea [42], and more recently, modulation
of dorsal horn trigeminovascular neurons [43]. Further supporting
this hypothalamic connection is the finding that the A11
dopaminergic cell group in the medial hypothalamus innervates
trigeminovascular neurons in both, the medullary dorsal horn
[44,45] and the thalamic relay nuclei [28]. The rich innervation of
thalamic trigeminovascular neurons by TH-positive fibers suggests
that modulation of transmission of nociceptive trigeminovascular
Figure 5. Close apposition between chemically-identified axons and thalamic trigeminovascular neurons. Images from the original z-
stack (obtained every 1 mm) were used to create orthogonal views in the y–z and x–z planes. The three views provide evidence that SERT
immunopositive fibers (green) may contact cell bodies, proximal and distal dendrites of trigeminovascular neurons in Po (red; as shown in Fig. 4).
Note that some green-labeled axons and red-labeled soma or dendrites are in the same focal plane (yellow). To see similar images for all the
neurotransmitters and neuropeptides identified in this study, see Supplementary Figures 1–7. Caveat: proximity between the chemically-identified
axons and the TMR-labeled trigeminovascular thalamic neurons suggests that they are innervated by the different neuropeptides/neurotransmitters.
Definitive evidence for actual synapses, however, requires tissue examination with electron microscopy. Scale bar=50 mm.
doi:10.1371/journal.pone.0103929.g005
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conceptualizing dopamine role in migraine, a consideration should
be given to the activation of thalamic D1 and D2 receptors which
facilitate membrane depolarization and increase spike discharge in
somatosensory VPL/VPM thalamic neurons [46], and to the
selective uptake of cocaine by dopaminergic nerve terminals in the
thalamus as these findings define the possibility that thalamic
dopamine pathways may be critically involved in drug-addiction,
impulse control, affect, attention and decision making [47–53].
Translating these into clinical implications, thalamic dopamine
may thus be considered as a possible contributor to behaviors that
lead to medication-overuse headache and exacerbation of
headache by negative emotions, effort to control anger and
irritability, cognitive tasks that require attention and the need to
make mundane decisions.
Serotonin
Relevant to this study is that serotonin has long been implicated
in migraine pathophysiology [54,55], that this implication has lead
to the development of 5HT1B/1D receptor agonists (i.e., triptans)
Figure 6. Noradrenergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive Dopamine b-Hydroxylase axons (green)
surrounding a thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads
indicate close apposition of DBH positive axons and the cell body and dendrites of the labeled neuron. Upper right: Location of the dura-sensitive
neuron (red star) shown at left. Number in red indicates distance from bregma (mm). Lower right: Fluorescent image showing DBH labeling of cell
bodies in the locus coeruleus (LC) of the brainstem. Scale bars=100 mm.
doi:10.1371/journal.pone.0103929.g006
Figure 7. Dopaminergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive Tyrosine Hydroxylase axons (green)
surrounding a thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads
indicate close apposition of TH positive axons and the cell body and dendrites of the labeled neuron. Upper right: Location of the dura-sensitive
neuron (red star) shown at left. Number in red indicates distance from bregma (mm). Lower right: Fluorescent image showing TH labeling of cell
bodies in the hypothalamic A11 nucleus. Scale bars=100 mm. Caveat: TH is present in noradrenergic and dopaminergic cells, thus TH-positive
labeling must take into consideration these two neurotransmitters.
doi:10.1371/journal.pone.0103929.g007
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VPM and Po originating mainly in the rostral raphe [9,56–59],
and that depending on the amount of serotonin release in the
thalamus, it could be facilitatory (at low concentration) or
inhibitory (at high concentration) to relay neurons in VPM and
Po [60]. In principle, a high concentration of serotonin is
inhibitory whereas a low concentration is excitatory. Accordingly,
the very dense innervation of thalamic trigeminovasular neurons
observed in our study can provide an anatomical substrate for a
predominantly inhibitory effect of serotonin on transmission of
trigeminovascular information between the thalamus and the
cortex, as well as the inhibition of trigeminovascular thalamic
neurons by local administration of 5HT1 agonists [61]. Given the
latter, we were surprised by the total absence of 5HT1D receptors
in the thalamus. This finding suggests that the inhibition of
thalamic trigeminovascular neurons response to dural stimulation
occur at an earlier synapse along the trigeminovasculat pathway
[62], rather than in the thalamus. On a more global view,
serotonin, through its involvement in stress [63], anxiety [64],
depression [65], sleep [66], apetite [67], and learning [64] may
help facilitate the reciprocal relationship between these affective
and physiological states and migraine.
Figure 8. Histaminergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive Histamine axons (green) surrounding a
thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads indicate close
apposition of Histamine positive axons and the cell body and dendrites of the labeled neuron. Upper right: Location of the dura-sensitive neuron (red
star) shown at left. Number in red indicates distance from bregma (mm). Lower right: Fluorescent image showing Histamine labeling of cell bodies in
the dorsal and ventral tuberomammillary nuclei of the hypothalamus (DTM and VTM). Scale bars=100 mm.
doi:10.1371/journal.pone.0103929.g008
Figure 9. MCH innervation of thalamic trigeminovascular neurons. Left: Immunopositive Melanin Concentrating Hormone axons (green)
surrounding a thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads
indicate close apposition of MCH positive axons and the dendrites of the labeled neuron. Upper right: Location of the dura-sensitive neuron (red star)
shown at left. Number in red indicates distance from bregma (mm). Lower right: Fluorescent image showing MCH labeling of cell bodies in the lateral
hypothalamus (LH). Scale bars=100 mm. Abbreviations: ZID, zona incerta, dorsal; ZIV, zona incerta, ventral.
doi:10.1371/journal.pone.0103929.g009
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Because of the wide distribution of noradrenergic fibers in the
brain it is difficult to assign to this neurotransmitter a specific role
in certain function. Rather, it is thought to improve signal-to-noise
ratio in the firing of neurons that respond to sensory stimuli
[11,68–70] when conditions involve anticipation, reward, and
Figure 10. Orexinergic innervation of thalamic trigeminovascular neurons. Left: Immunopositive Orexin A axons (green) surrounding a
thalamic dura-sensitive neuron (red) labeled with TMR–dextran. Nuclear counterstaining was performed with DAPI (blue). Arrowheads indicate close
apposition of OrA positive axons and the dendrites of the labeled neuron. Upper right: Location of the dura-sensitive neuron (red star) shown at left.
Number in red indicates distance from bregma (mm). Lower right: Fluorescent image showing OrA labeling of cell bodies in the hypothalamic
perifornical area (PeF). Scale bars=100 mm. Abbreviation: LDVL, laterodorsal thalamic, ventrolateral.
doi:10.1371/journal.pone.0103929.g010
Figure 11. Lack of innervation of thalamic trigeminovascular neurons by axons containing CGRP, Serotonin 1D receptor, Oxytocin
and Vasopressin. Left A–D: Thalamic dura-sensitive neurons (red) labeled with TMR–dextran and nuclear counterstain with DAPI (blue). Note the
absence of axonal immunoreactivity to CGRP (A), Serotonin 1D receptor (B), Oxytocin (C) and Vasopressin (D). Upper right A–D: Locations of the dura-
sensitive neurons (red stars) shown at left. Numbers in red indicate distance from bregma (mm). Lower right A–B: Fluorescent images showing CGRP
(A) and Serotonin 1D receptor (B) immunopositive axons in the parvicellular division of the ventral posterior thalamic nucleus (VPpc) and the spinal
trigeminal nuclei (SpVC/SpVI; caudal/interpolar), respectively. Lower right C: Fluorescent images showing Oxytocin labeling of cell bodies and axons
in the hypothalamic paraventricular nucleus (PVN) and lateral hypothalamus (LH), respectively. Lower right D: Fluorescent images showing
Vasopressin labeling of cell bodies in the PVN and circular (Cir) nuclei of the hypothalamus, and axons in the LH. Scale bars=100 mm.
doi:10.1371/journal.pone.0103929.g011
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position to modulate thalamic neurons, noradrenergic fibers
project heavily to all thalamic sensory nuclei [72,73] and act on
both a and b adrenoceptors, which together modulate firing rate,
set a pacemaker current, determine membrane resting potential,
and synaptic strength [74–77]. In the context of migraine,
noradrenaline, which usually prolongs the activation of thalamic
neurons [78–81], may be involved in setting abnormal excitability
level in trigeminovascular neurons, centrally, and the magnitude of
arterial hypertension, peripherally. This view is supported by the
finding that b1 adrenoceptor blockers, which are among the very
few drugs approved as migraine prophylactics [82], inhibit the
activity of thalamic trigeminovascular neurons [83]. The observed
relationship between noradrenergic fibers and thalamic trigemi-
novascular neurons provide a direct anatomical substrate for the
central action of b1 adrenoceptor blockers in migraine. Given that
activation of b1 adrenoceptor enhances the hyperpolarization-
activated cation current (Ih) responsible for setting the so-called
pacemaker activity level and the resting membrane potential in
those relay thalamic neurons that exhibit such current [74,76,77],
it is reasonable to speculate that thalamic trigeminovascular
neurons exhibit the hyperpolarization-activated cation current – a
current that may render them likely to exhibit a prolonged firing
mode.
Histamine
In the context of migraine, histamine has been considered for its
role in causing H1 receptor mediated arterial dilatation and the
consequential induction of delayed headache [84]. The findings
that histaminergic nerve terminals converge on thalamic trigemi-
novascular neurons suggest that histamine role in migraine may
also include modulation of thalamic trigeminovascular neurons
through excitatory H1 receptors whose action enhances slow
depolarization current capable of switching neuronal discharge
mode from burst to tonic [85]. In the CNS, histamine originates
exclusively from neurons of the tuberomammillary hypothalamic
nucleus [17,18]. Given that these neurons are active during the
wake-state and quiescent during the sleep state [86–88] and that
histamine switches the firing mode of relay thalamic neurons from
burst to tonic [3,85], it is tempting to speculate that the
modulation of thalamic trigeminovascular neurons by the hista-
minergic pathway may play a role in the partial, or even complete,
headache relief provided by sleep.
Melanin Concentrating Hormone
The MCH system, which originates in the hypothalamus and
contains GABA [89] is thought to play a modulatory/inhibitory
role in the regulation of energy expenditure, arousal, locomotion,
sexual behavior and a variety of autonomic functions [90–94].
Being excited by increased glucose level after a meal, MCH
neurons are thought to promote sleep and energy expenditure (i.e.,
cessation of food intake) by releasing GABA at multiple cortical,
subcortical, brainstem and spinal areas they project to. To date,
this system has not been considered in the pathophysiology of
migraine or other headaches. The findings that hypothalamic
MCH neurons issue axons that terminate on thalamic trigemino-
vascular neurons define a novel anatomo-functional substrate for
hypothesizing about possible interactions between food intake,
drowsiness and migraine. It is tempting to propose that the
mechanism by which eating may make patients ‘feel better’ during
migraine involves increased level of glucose, activation of
hypothalamic MCH neurons [95], and the consequential inhibi-
tion of relay thalamic trigeminovascular neurons. Conversely, this
anatomo-functional substrate may also explain a part of the
reasons for why migraine is promoted by skipping a meal.
Skipping a meal inhibits MCH neurons (as glucose level goes
down) that, when inactive, may release far less GABA around
thalamic trigeminovascular neurons. Reduced GABA input might
then enhance neuronal excitability, rendering them more likely to
respond to subthreshold input they receive from ascending dura-
sensitive neurons in the spinal trigeminal nucleus.
Orexin
The orexin system originates in the lateral hypothalamus (LH)
and projects to the cortex, thalamus, brainstem, spinal cord and
other hypothalamic nuclei [20,96–99]. It consists of 2 neuropep-
tides (orexin A, orexin B) that are synthesized by the same gene
[100] and act on 2 classes of receptors, the selective orexin
receptor 1 (orexin A) and the non-selective orexin receptor 2
(orexin A and B). The wide distribution of orexin fibers in the
brain support a role in regulating food intake, arousal, wakefulness
Table 1. Relative density of thalamic innervation by neurotransmitters and neuropeptides.
Positive Pixels Negative Pixels Positive Pixels (%) Density
VGluT2 139,571 1,308,109 9.64 High
TH 124,675 1,323,005 8.61 High
VGaT 106,398 1,341,282 7.35 High
SERT 82,190 1,365,490 5.68 High
DBH 46,331 1,401,349 3.20 Moderate
Hist 17,578 1,430,102 1.21 Moderate
Orexin 8,555 1,439,125 0.59 Low
MCH 7,153 1,440,527 0.49 Low
CGRP 0 1,447,680 0.0 Absent
5HT1D 0 1,447,680 0.0 Absent
Vaso 0 1,447,680 0.0 Absent
Oxy 0 1,447,680 0.0 Absent
Quantitative analysis using binary maps: .5% of positive (white) pixels per image indicates high density, 1–5% indicates moderate density, and ,1% indicates low
density of innervation. See Figs. S8 and S9 for actual binary maps.
doi:10.1371/journal.pone.0103929.t001
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rate and blood pressure [101]. Opposite to the function of the
MCH system, orexin neurons are excited by falling glucose levels,
and their activation promotes food intake and wakefulness [102–
104]. Of potential relevance to the pathophysiology of migraine
are orexinergic axons in nociceptive laminae of the medullary
dorsal horn and in close apposition to thalamic trigeminovascular
neurons. Although no information is available regarding the
direction in which orexin modulates thalamic trigeminovascular
neurons, in vitro slice recording of thalamic neurons suggests that
both orexin B and, for a lesser extent, orexin A are capable of
depolarizing these neurons sufficently to switch their firing from
the sleep-associated burst mode to the wakefulness-associated tonic
mode [105]. In the context of migraine, it is thus reasonable to
hypothesize that the mechanism by which eating may reduce
headache intensity involves not only local release of GABA from
activated MCH neurons but also inhibition of facilitatory orexin
input to thalamic trigeminovascular neurons induced by increased
glucose level (orexin neurons are inhibited by glucose). And
conversely, fasting-induced fall in glucose activates the orexinergic
neurons which in turn facilitate excitability through local release of
orexin B and A.
Calcitonin Gene Related Peptide
A large number of studies suggest that CGRP plays an
important role in multiple aspects of migraine pathophysiolopgy
[106]. Of particular relevance to the current study is the Summ et
al., paper [107] demonstrating presence of CGRP receptors in
VPM and consequently, inhibition of thalamic trigeminovascular
neurons by systemic and local administration of CGRP receptor
antagonists. The absence of CGRP-positive fibers in the vicinity of
thalamic trigeminovascular neurons raises the possibility that
CGRP release is not localized within the thalamus but rather may
be released at a distant location of the receptors, acting as a
neurohormone.
The thalamus is intricately connected with multiple cortical,
subcortical and brainstem regions. It is viewed as an important
subcortical hub with respect to functional brain networks [108]
involved in processes that are altered in certain disease states
[109,110]. In the migraine brain, changes in modulation of
Figure 12. (A) Schematic illustration of the neurotransmitter and neuropeptidergic systems innervating thalamic trigeminovascular
neurons in VPM, Po and LP/LD. The peripheral (meningeal nociceptors) and central (trigemino-thalamic) components of the trigeminovascular
pathway are shown in red. The neurotransmitter and neuropeptidergic systems are color coded as follow: (a) Glutamate from SpVC/C1-2 in red; (b)
GABA from Rt in yellow; (c) Noradrenalin from LC in blue; (d) Serotonin from raphe magnus (RMg) and dorsal raphe (DR) in green; (e) Histamine from
DTM and VTM in orange; (f) Melanin Concentrating Hormone from LH in purple; (g) Orexin from PeF in black; (h) Dopamine from A11 in brown. (B)
The diverse neurochemical pathways that converge on thalamic trigeminovascular neurons and the probability that many of them modulate
neuronal activity in the same direction under certain conditions (e.g., sleep deprivation, wakefulness, food withhold, stress, anxiety) and in opposite
directions under other conditions (e.g., food intake, sleep) define a sophisticated neuroanatomical network that may help us conceptualize how
sensory, physiological, cognitive and affective conditions trigger, worsen or improve migraine headache.
doi:10.1371/journal.pone.0103929.g012
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thalamic functional connectivity during both the interictal and the
ictal state. The diverse neurochemical pathways that converge on
thalamic trigeminovascular neurons (Fig. 12A–B) and the proba-
bility that many of them modulate neuronal activity in the same
direction under certain conditions (e.g., sleep deprivation) and in
opposite directions under other conditions (e.g., when satiated or
scared) define a sophisticated neuroanatomical network that may
help us conceptualize how sensory, physiological, cognitive and
affective conditions trigger, worsen or improve migraine headache.
Supporting Information
Figure S1 Close apposition between VGluT2 immuno-
positive vesicles and thalamic trigeminovascular neu-
rons. The three views in the x–y, y–z and x–z planes provide
evidence that VGluT2 immunopositive vesicles (green) may
contact cell bodies, proximal and distal dendrites of trigemino-
vascular neurons in LP (red; as shown in Fig. 2). Arrowheads
indicate probable contact point on each view. Note that some
green-labeled vesicles and red-labeled soma or dendrites are in the
same focal plane (yellow). Scale bar=50 mm.
(TIFF)
Figure S2 Close apposition between VGaT immunopo-
sitive vesicles and thalamic trigeminovascular neurons.
The three views in the x–y, y–z and x–z planes provide evidence
that VGaT immunopositive vesicles (green) may contact cell
bodies, proximal and distal dendrites of trigeminovascular neurons
in VPM (red; as shown in Fig. 3). Arrowheads indicate probable
contact point on each view. Note that some green-labeled vesicles
and red-labeled soma or dendrites are in the same focal plane
(yellow). Scale bar=50 mm.
(TIFF)
Figure S3 Close apposition between DBH immunoposi-
tive axons and thalamic trigeminovascular neurons. The
three views in the x–y, y–z and x–z planes provide evidence that
DBH immunopositive fibers (green) may contact cell bodies,
proximal and distal dendrites of trigeminovascular neurons in Po
(red; as shown in Fig. 6). Arrowheads indicate probable contact
point on each view. Note that some green-labeled axons and red-
labeled soma or dendrites are in the same focal plane (yellow).
Scale bar=50 mm.
(TIFF)
Figure S4 Close apposition between TH immunoposi-
tive axons and thalamic trigeminovascular neurons. The
three views in the x–y, y–z and x–z planes provide evidence that
TH immunopositive fibers (green) may contact proximal and distal
dendrites of trigeminovascular neurons in Po (red; as shown in
Fig. 7). Arrowheads indicate probable contact point on each view.
Note that some green-labeled axons and red-labeled dendrites are
in the same focal plane (yellow). Scale bar=50 mm.
(TIFF)
Figure S5 Close apposition between Histamine immu-
nopositive axons and thalamic trigeminovascular neu-
rons. The three views in the x–y, y–z and x–z planes provide
evidence that Histamine immunopositive fibers (green) may
contact cell bodies, proximal and distal dendrites of trigemino-
vascular neurons in LP (red; as shown in Fig. 8). Arrowheads
indicate probable contact point on each view. Note that some
green-labeled axons and red-labeled soma or dendrites are in the
same focal plane (yellow). Scale bar=50 mm.
(TIFF)
Figure S6 Close apposition between MCH immunopo-
sitive axons and thalamic trigeminovascular neurons.
The three views in the x–y, y–z and x–z planes provide evidence
that MCH immunopositive fibers (green) may contact distal
dendrites of trigeminovascular neurons in VPM (red; as shown in
Fig. 9). Arrowheads indicate probable contact point on each view.
Note that some green-labeled axons and red-labeled dendrites are
in the same focal plane (yellow). Scale bar=50 mm.
(TIFF)
Figure S7 Close apposition between Orexin A immuno-
positive axons and thalamic trigeminovascular neurons.
The three views in the x–y, y–z and x–z planes provide evidence
that Orexin A immunopositive fibers (green) may contact proximal
and distal dendrites of trigeminovascular neurons in LD (red; as
shown in Fig. 10). Arrowheads indicate probable contact point on
each view. Note that some green-labeled axons and red-labeled
dendrites are in the same focal plane (yellow). Scale bar=50 mm.
(TIFF)
Figure S8 Density maps of thalamic innervation by
neurotransmitters and neuropeptides. Left: photomicro-
graphs showing immunofluorescence staining of each biomarker in
thalamic areas where juxtacellularly labeled trigeminovascular
neurons were recorded (for anatomical reference, see figures 2–6).
Right: Binary heat maps obtained from the images on the left
showing all pixels (in red) containing positive immunostaining.
Based on this data, objective measures to quantify density of
innervation were obtained and defined as follow: High: .5% of
positive pixels per image; Moderate: 1–5%; Low: ,1%. The
relative density of innervation by VGluT2, VGaT, SERT, DBH is
9.64% (high), 7.35% (high), 5.68% (high) and 3.2% (moderate) of
positive pixels, respectively. Scale bar=100 mm.
(TIFF)
Figure S9 Density maps of thalamic innervation by
neurotransmitters and neuropeptides. Left: photomicro-
graphs showing immunofluorescence staining of each biomarker in
thalamic areas where juxtacellularly labeled trigeminovascular
neurons were recorded (for anatomical reference, see figures 7–
10). Right: Binary heat maps obtained from the images on the left
showing all pixels (in red) containing positive immunostaining.
The relative density of innervation by TH, Histamine, Orexin and
MCH is 8.61% (high), 1.21% (moderate), 0.59% (low) and 0.49%
(low) of positive pixels, respectively. Scale bar=100 mm.
(TIFF)
Author Contributions
Conceived and designed the experiments: RN RB. Performed the
experiments: RN VK. Analyzed the data: RN VK DB RB. Wrote the
paper: RN DB RB.
References
1. Sherman SM (2005) Thalamic relays and cortical functioning. Prog Brain Res
149: 107–126.
2. Sherman SM, Guillery RW (1998) On the actions that one nerve cell can have
on another: Distinguishing ‘‘drivers’’ from ‘‘modulators’’. Proceedings of the
National Academy of Sciences of the United States of America 95: 7121–7126.
3. McCormick DA (1992) Neurotransmitter actions in the thalamus and cerebral
cortex and their role in neuromodulation of thalamocortical activity. Prog
Neurobiol 39: 337–388.
4. Steriade M, McCormick DA, Sejnowski TJ (1993) Thalamocortical oscillations
in the sleeping and aroused brain. Science 262: 679–685.
Modulation of Thalamic Trigeminovascular Neurons
PLOS ONE | www.plosone.org 12 August 2014 | Volume 9 | Issue 8 | e1039295. Guillery RW, Sherman SM (2002) Thalamic relay functions and their role in
corticocortical communication: generalizations from the visual system. Neuron
33: 163–175.
6. Sherman SM, Guillery RW (1996) Functional organization of thalamocortical
relays. J Neurophysiol 76: 1367–1395.
7. Kaneko T, Mizuno N (1988) Immunohistochemical study of glutaminase-
containing neurons in the cerebral cortex and thalamus of the rat. J Comp
Neurol 267: 590–602.
8. McCormick DA, von Krosigk M (1992) Corticothalamic activation modulates
thalamic firing through glutamate ‘‘metabotropic’’ receptors. Proc Natl Acad
Sci U S A 89: 2774–2778.
9. Westlund KN, Sorkin LS, Ferrington DG, Carlton SM, Willcockson HH, et al.
(1990) Serotoninergic and noradrenergic projections to the ventral posterolat-
eral nucleus of the monkey thalamus. J Comp Neurol 295: 197–207.
10. Papadopoulos GC, Parnavelas JG (1990) Distribution and synaptic organiza-
tion of serotoninergic and noradrenergic axons in the lateral geniculate nucleus
of the rat. J Comp Neurol 294: 345–355.
11. Morrison JH, Foote SL (1986) Noradrenergic and serotoninergic innervation of
cortical, thalamic, and tectal visual structures in Old and New World monkeys.
J Comp Neurol 243: 117–138.
12. Papadopoulos GC, Parnavelas JG (1990) Distribution and synaptic organiza-
tion of dopaminergic axons in the lateral geniculate nucleus of the rat. J Comp
Neurol 294: 356–361.
13. Groenewegen HJ (1988) Organization of the afferent connections of the
mediodorsal thalamic nucleus in the rat, related to the mediodorsal-prefrontal
topography. Neuroscience 24: 379–431.
14. Sanchez-Gonzalez MA, Garcia-Cabezas MA, Rico B, Cavada C (2005) The
primate thalamus is a key target for brain dopamine. J Neurosci 25: 6076–
6083.
15. Garcia-Cabezas MA, Rico B, Sanchez-Gonzalez MA, Cavada C (2007)
Distribution of the dopamine innervation in the macaque and human
thalamus. Neuroimage 34: 965–984.
16. Garcia-Cabezas MA, Martinez-Sanchez P, Sanchez-Gonzalez MA, Garzon M,
Cavada C (2009) Dopamine innervation in the thalamus: monkey versus rat.
Cereb Cortex 19: 424–434.
17. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic
transmission in the mammalian brain. Physiol Rev 71: 1–51.
18. Panula P, Pirvola U, Auvinen S, Airaksinen MS (1989) Histamine-
immunoreactive nerve fibers in the rat brain. Neuroscience 28: 585–610.
19. Sakurai T (2007) The neural circuit of orexin (hypocretin): maintaining sleep
and wakefulness. Nat Rev Neurosci 8: 171–181.
20. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, et al. (1999)
Distribution of orexin neurons in the adult rat brain. Brain Res 827: 243–260.
21. Bittencourt JC, Frigo L, Rissman RA, Casatti CA, Nahon JL, et al. (1998) The
distribution of melanin-concentrating hormone in the monkey brain (Cebus
apella). Brain Res 804: 140–143.
22. Adamantidis A, de Lecea L (2009) A role for Melanin-Concentrating Hormone
in learning and memory. Peptides 30: 2066–2070.
23. Hervieu GJ, Cluderay JE, Harrison D, Meakin J, Maycox P, et al. (2000) The
distribution of the mRNA and protein products of the melanin-concentrating
hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat.
Eur J Neurosci 12: 1194–1216.
24. Noseda R, Jakubowski M, Kainz V, Borsook D, Burstein R (2011) Cortical
projections of functionally identified thalamic trigeminovascular neurons:
implications for migraine headache and its associated symptoms. J Neurosci 31:
14204–14217.
25. Pinault D (1996) A novel single-cell staining procedure performed in vivo
under electrophysiological control: Morpho-functional features of juxtacellu-
larly labeled thalamic cells and other central neurons with biocytin or
Neurobiotin. Journal of Neuroscience Methods 65: 113–136.
26. Paxinos G, Watson C (2008) The Rat Brain in Stereotaxic Coordinates:
Academic Press.
27. Nielsen K, Brask D, Knudsen GM, Aznar S (2006) Immunodetection of the
serotonin transporter protein is a more valid marker for serotonergic fibers than
serotonin. Synapse 59: 270–276.
28. Kagan R, Kainz V, Burstein R, Noseda R (2013) Hypothalamic and basal
ganglia projections to the posterior thalamus: Possible role in modulation of
migraine headache and photophobia. Neuroscience 248C: 359–368.
29. Steriade M, Deschenes M (1984) The thalamus as a neuronal oscillator. Brain
Res 320: 1–63.
30. McCarley RW, Benoit O, Barrionuevo G (1983) Lateral geniculate nucleus
unitary discharge in sleep and waking: state- and rate-specific aspects.
J Neurophysiol 50: 798–818.
31. Steriade M, Domich L, Oakson G (1986) Reticularis thalami neurons revisited:
activity changes during shifts in states of vigilance. J Neurosci 6: 68–81.
32. McCormick DA, Bal T (1997) Sleep and arousal: thalamocortical mechanisms.
Annu Rev Neurosci 20: 185–215.
33. Salt TE, Eaton SA (1989) Function of non-NMDA receptors and NMDA
receptors in synaptic responses to natural somatosensory stimulation in the
ventrobasal thalamus. Exp Brain Res 77: 646–652.
34. Deschenes M, Hu B (1990) Membrane resistance increase induced in thalamic
neurons by stimulation of brainstem cholinergic afferents. Brain Res 513: 339–
342.
35. Barroso-Chinea P, Castle M, Aymerich MS, Lanciego JL (2008) Expression of
vesicular glutamate transporters 1 and 2 in the cells of origin of the rat
thalamostriatal pathway. J Chem Neuroanat 35: 101–107.
36. Varoqui H, Schafer MK, Zhu H, Weihe E, Erickson JD (2002) Identification of
the differentiation-associated Na+/PI transporter as a novel vesicular glutamate
transporter expressed in a distinct set of glutamatergic synapses. J Neurosci 22:
142–155.
37. Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, et al. (2001) The
existence of a second vesicular glutamate transporter specifies subpopulations of
glutamatergic neurons. J Neurosci 21: RC181.
38. Fremeau RT, Jr., Kam K, Qureshi T, Johnson J, Copenhagen DR, et al. (2004)
Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic
release sites. Science 304: 1815–1819.
39. Fremeau RT, Jr., Troyer MD, Pahner I, Nygaard GO, Tran CH, et al. (2001)
The expression of vesicular glutamate transporters defines two classes of
excitatory synapse. Neuron 31: 247–260.
40. Graziano A, Liu XB, Murray KD, Jones EG (2008) Vesicular glutamate
transporters define two sets of glutamatergic afferents to the somatosensory
thalamus and two thalamocortical projections in the mouse. J Comp Neurol
507: 1258–1276.
41. Ge SN, Ma YF, Hioki H, Wei YY, Kaneko T, et al. (2010) Coexpression of
VGLUT1 and VGLUT2 in trigeminothalamic projection neurons in the
principal sensory trigeminal nucleus of the rat. J Comp Neurol 518: 3149–
3168.
42. Sicuteri F (1977) Dopamine, the second putative protagonist in headache.
Headache 17: 129–131.
43. Bergerot A, Storer RJ, Goadsby PJ (2007) Dopamine inhibits trigeminovascular
transmission in the rat. Ann Neurol 61: 251–262.
44. Takada M, Li ZK, Hattori T (1988) Single thalamic dopaminergic neurons
project to both the neocortex and spinal cord. Brain Res 455: 346–352.
45. Skagerberg G, Lindvall O (1985) Organization of diencephalic dopamine
neurones projecting to the spinal cord in the rat. Brain Res 342: 340–351.
46. Govindaiah G, Wang Y, Cox CL (2010) Dopamine enhances the excitability of
somatosensory thalamocortical neurons. Neuroscience 170: 981–991.
47. Rondou P, Haegeman G, Van Craenenbroeck K (2010) The dopamine D4
receptor: biochemical and signalling properties. Cell Mol Life Sci 67: 1971–
1986.
48. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychophar-
macology 35: 217–238.
49. Iversen SD, Iversen LL (2007) Dopamine: 50 years in perspective. Trends
Neurosci 30: 188–193.
50. Takahashi H, Higuchi M, Suhara T (2006) The role of extrastriatal dopamine
D2 receptors in schizophrenia. Biol Psychiatry 59: 919–928.
51. Di Chiara G (2002) Nucleus accumbens shell and core dopamine: differential
role in behavior and addiction. Behav Brain Res 137: 75–114.
52. Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine
does and doesn’t do. Curr Opin Pharmacol 7: 69–76.
53. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine
receptors: from structure to function. Physiol Rev 78: 189–225.
54. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials
as an indicator of central serotonergic neurotransmission: a new hypothesis.
Biol Psychiatry 33: 173–187.
55. Sicuteri F (1972) Headache as possible expression of deficiency of brain 5-
hydroxytryptamine (central denervation supersensitivity). Headache 12: 69–72.
56. Westlund KN, Sorkin LS, Ferrington DG, Carlton SM, Willcockson HH, et al.
(1990) Serotoninergic and noradrenergic projections to the ventral posterolat-
eral nucleus of the monkey thalamus. Journal of Comparative Neurology 295:
197–207.
57. Nothias F, Onteniente B, Roudier F, Peschanksi M (1988) Immunocytochem-
ical study of serotoninergic and noradrenergic innervation of the ventrobasal
complex of the rat thalamus. Neurosci Lett 95: 59–63.
58. Moore RY, Halaris AE, Jones BE (1978) Serotonin neurons of the midbrain
raphe: ascending projections. J Comp Neurol 180: 417–438.
59. Consolazione A, Priestley JV, Cuello AC (1984) Serotonin-containing
projections to the thalamus in the rat revealed by a horseradish peroxidase
and peroxidase antiperoxidase double-staining technique. Brain Res 322: 233–
243.
60. Eaton SA, Salt TE (1989) Modulatory effects of serotonin on excitatory amino
acid responses and sensory synaptic transmission in the ventrobasal thalamus.
Neuroscience 33: 285–292.
61. Shields KG, Goadsby PJ (2006) Serotonin receptors modulate trigeminovas-
cular responses in ventroposteromedial nucleus of thalamus: a migraine target?
Neurobiol Dis 23: 491–501.
62. Levy D, Jakubowski M, Burstein R (2004) Disruption of communication
between peripheral and central trigeminovascular neurons mediates the
antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad
Sci U S A 101: 4274–4279.
63. Lopez JF, Akil H, Watson SJ (1999) Neural circuits mediating stress. Biol
Psychiatry 46: 1461–1471.
64. Homberg JR (2012) Serotonin and decision making processes. Neurosci
Biobehav Rev 36: 218–236.
65. Meltzer H (1989) Serotonergic dysfunction in depression. Br J Psychiatry
Suppl: 25–31.
Modulation of Thalamic Trigeminovascular Neurons
PLOS ONE | www.plosone.org 13 August 2014 | Volume 9 | Issue 8 | e10392966. Green AR (2006) Neuropharmacology of 5-hydroxytryptamine. Br J Pharma-
col 147 Suppl 1: S145–152.
67. Yeo GS, Heisler LK (2012) Unraveling the brain regulation of appetite: lessons
from genetics. Nat Neurosci 15: 1343–1349.
68. Ego-Stengel V, Bringuier V, Shulz DE (2002) Noradrenergic modulation of
functional selectivity in the cat visual cortex: an in vivo extracellular and
intracellular study. Neuroscience 111: 275–289.
69. Devilbiss DM, Waterhouse BD (2004) The effects of tonic locus ceruleus output
on sensory-evoked responses of ventral posterior medial thalamic and barrel
field cortical neurons in the awake rat. J Neurosci 24: 10773–10785.
70. Berridge CW, Schmeichel BE, Espana RA (2012) Noradrenergic modulation of
wakefulness/arousal. Sleep Med Rev 16: 187–197.
71. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic
system: modulation of behavioral state and state-dependent cognitive processes.
Brain Res Brain Res Rev 42: 33–84.
72. Lindvall O, Bjorklund A, Nobin A, Stenevi U (1974) The adrenergic
innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence
method. J Comp Neurol 154: 317–347.
73. De Lima AD, Singer W (1987) The brainstem projection to the lateral
geniculate nucleus in the cat: identification of cholinergic and monoaminergic
elements. J Comp Neurol 259: 92–121.
74. Pape HC, McCormick DA (1989) Noradrenaline and serotonin selectively
modulate thalamic burst firing by enhancing a hyperpolarization-activated
cation current. Nature 340: 715–718.
75. Luthi A, McCormick DA (1998) Periodicity of thalamic synchronized
oscillations: the role of Ca2+-mediated upregulation of Ih. Neuron 20: 553–
563.
76. Luthi A, McCormick DA (1998) H-current: properties of a neuronal and
network pacemaker. Neuron 21: 9–12.
77. Robinson RB, Siegelbaum SA (2003) Hyperpolarization-activated cation
currents: from molecules to physiological function. Annu Rev Physiol 65:
453–480.
78. Rogawski MA, Aghajanian GK (1980) Norepinephrine and serotonin: opposite
effects on the activity of lateral geniculate neurons evoked by optic pathway
stimulation. Exp Neurol 69: 678–694.
79. Rogawski MA, Aghajanian GK (1980) Modulation of lateral geniculate
neurone excitability by noradrenaline microiontophoresis or locus coeruleus
stimulation. Nature 287: 731–734.
80. Kayama Y, Negi T, Sugitani M, Iwama K (1982) Effects of locus coeruleus
stimulation on neuronal activities of dorsal lateral geniculate nucleus and
perigeniculate reticular nucleus of the rat. Neuroscience 7: 655–666.
81. Kayama Y (1985) Ascending, descending and local control of neuronal activity
in the rat lateral geniculate nucleus. Vision Res 25: 339–347.
82. Welch KM (1993) Drug therapy of migraine. N Engl J Med 329: 1476–1483.
83. Shields KG, Goadsby PJ (2005) Propranolol modulates trigeminovascular
responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain
128: 86–97.
84. Krabbe AA, Olesen J (1980) Headache provocation by continuous intravenous
infusion of histamine. Clinical results and receptor mechanisms. Pain 8: 253–
259.
85. McCormick DA, Williamson A (1991) Modulation of neuronal firing mode in
cat and guinea pig LGNd by histamine: possible cellular mechanisms of
histaminergic control of arousal. J Neurosci 11: 3188–3199.
86. Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine.
Prog Neurobiol 63: 637–672.
87. Monti JM (1993) Involvement of histamine in the control of the waking state.
Life Sci 53: 1331–1338.
88. Lin JS, Sakai K, Jouvet M (1988) Evidence for histaminergic arousal
mechanisms in the hypothalamus of cat. Neuropharmacology 27: 111–122.
89. Elias CF, Lee CE, Kelly JF, Ahima RS, Kuhar M, et al. (2001)
Characterization of CART neurons in the rat and human hypothalamus.
J Comp Neurol 432: 1–19.
90. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbauer ME, et al. (2002)
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperac-
tive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A
99: 3240–3245.
91. Hassani OK, Lee MG, Jones BE (2009) Melanin-concentrating hormone
neurons discharge in a reciprocal manner to orexin neurons across the sleep-
wake cycle. Proc Natl Acad Sci U S A 106: 2418–2422.
92. Astrand A, Bohlooly YM, Larsdotter S, Mahlapuu M, Andersen H, et al. (2004)
Mice lacking melanin-concentrating hormone receptor 1 demonstrate
increased heart rate associated with altered autonomic activity. Am J Physiol
Regul Integr Comp Physiol 287: R749–758.
93. Gonzalez MI, Vaziri S, Wilson CA (1996) Behavioral effects of alpha-MSH and
MCH after central administration in the female rat. Peptides 17: 171–177.
94. Segal-Lieberman G, Bradley RL, Kokkotou E, Carlson M, Trombly DJ, et al.
(2003) Melanin-concentrating hormone is a critical mediator of the leptin-
deficient phenotype. Proc Natl Acad Sci U S A 100: 10085–10090.
95. Burdakov D, Gerasimenko O, Verkhratsky A (2005) Physiological changes in
glucose differentially modulate the excitability of hypothalamic melanin-
concentrating hormone and orexin neurons in situ. J Neurosci 25: 2429–2433.
96. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, et al. (1998)
Neurons containing hypocretin (orexin) project to multiple neuronal systems.
J Neurosci 18: 9996–10015.
97. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, et al. (1998)
Chemically defined projections linking the mediobasal hypothalamus and the
lateral hypothalamic area. J Comp Neurol 402: 442–459.
98. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, et al. (1999)
Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuro-
endocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 96: 748–
753.
99. Broberger C, De Lecea L, Sutcliffe JG, Hokfelt T (1998) Hypocretin/orexin-
and melanin-concentrating hormone-expressing cells form distinct populations
in the rodent lateral hypothalamus: relationship to the neuropeptide Y and
agouti gene-related protein systems. J Comp Neurol 402: 460–474.
100. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, et al. (1998)
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G
protein-coupled receptors that regulate feeding behavior. Cell 92: 573–585.
101. Girault EM, Yi CX, Fliers E, Kalsbeek A (2012) Orexins, feeding, and energy
balance. Prog Brain Res 198: 47–64.
102. Leinninger GM (2011) Lateral thinking about leptin: a review of leptin action
via the lateral hypothalamus. Physiol Behav 104: 572–581.
103. Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, et al. (2003)
Hypothalamic orexin neurons regulate arousal according to energy balance in
mice. Neuron 38: 701–713.
104. Kelz MB, Sun Y, Chen J, Cheng Meng Q, Moore JT, et al. (2008) An essential
role for orexins in emergence from general anesthesia. Proc Natl Acad
Sci U S A 105: 1309–1314.
105. Govindaiah G, Cox CL (2006) Modulation of thalamic neuron excitability by
orexins. Neuropharmacology 51: 414–425.
106. Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new
insights into migraine pathophysiology. Nat Rev Neurol 6: 573–582.
107. Summ O, Charbit AR, Andreou AP, Goadsby PJ (2010) Modulation of
nocioceptive transmission with calcitonin gene-related peptide receptor
antagonists in the thalamus. Brain 133: 2540–2548.
108. Tomasi D, Volkow ND (2011) Association between functional connectivity
hubs and brain networks. Cereb Cortex 21: 2003–2013.
109. Wang Z, Jia X, Liang P, Qi Z, Yang Y, et al. (2012) Changes in thalamus
connectivity in mild cognitive impairment: evidence from resting state fMRI.
Eur J Radiol 81: 277–285.
110. Nathan DE, Wang BQ, Wolfowitz RD, Liu W, Yeh PH, et al. (2012)
Examining intrinsic thalamic resting state networks using graph theory analysis:
implications for mTBI detection. Conf Proc IEEE Eng Med Biol Soc 2012:
5445–5448.
Modulation of Thalamic Trigeminovascular Neurons
PLOS ONE | www.plosone.org 14 August 2014 | Volume 9 | Issue 8 | e103929